REBECCA VAGLIO: Open Payments
NPI 1962955690 · FORT MILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,623 in 137 payments from 17 companies in 2025. Trend: 2023 $4,324 · 2024 $4,644 · 2025 $4,623
Food & beverage: $3,025Consulting: $1,330Education: $268
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $1,499 |
| Janssen Biotech, Inc. | 29 | $641 |
| GENZYME CORPORATION | 17 | $559 |
| ABBVIE INC. | 20 | $450 |
| Arcutis Biotherapeutics, Inc. | 12 | $299 |
| Regeneron Healthcare Solutions, Inc. | 4 | $202 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $165 |
| Lilly USA, LLC | 5 | $148 |
| E.R. Squibb & Sons, L.L.C. | 11 | $136 |
| Organon LLC | 5 | $122 |
Products named: Bimzelx, TREMFYA, DUPIXENT, Zoryve, RINVOQ, SKYRIZI, Sotyktu, LIBTAYO.
Industry payments across SC — which companies pay providers there.
